Professor Kevin Healy has been awarded a grant from the FDA through the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI). The grant will cover collaborative research on “Multi-organ microphysiological systems for modeling clinical drug effects.”